Kimberly Chong

Array ( [id] => 6805042 [patent_doc_number] => 20030232436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Antisense modulation of E2-EPF expression' [patent_app_type] => new [patent_app_number] => 10/173240 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29656 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232436.pdf [firstpage_image] =>[orig_patent_app_number] => 10173240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774201 [patent_doc_number] => 20030017539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Novel nucleic acid sequences encoding G-protein coupled receptors' [patent_app_type] => new [patent_app_number] => 10/165844 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 100269 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 324 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017539.pdf [firstpage_image] =>[orig_patent_app_number] => 10165844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651320 [patent_doc_number] => 20030105051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Nucleic acid treatment of diseases or conditions related to levels of HER2' [patent_app_type] => new [patent_app_number] => 10/163552 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38366 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105051.pdf [firstpage_image] =>[orig_patent_app_number] => 10163552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678320 [patent_doc_number] => 20060183676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Treatment of mycobacterium tuberculosis with antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/478268 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25773 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183676.pdf [firstpage_image] =>[orig_patent_app_number] => 10478268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683152 [patent_doc_number] => 20030119016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Antisense oligonucleotides with increased RNase sensitivity' [patent_app_type] => new [patent_app_number] => 10/142566 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13077 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119016.pdf [firstpage_image] =>[orig_patent_app_number] => 10142566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074321 [patent_doc_number] => 20050147589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Compositions for delivering biologically active drug and method of using the same' [patent_app_type] => utility [patent_app_number] => 10/508554 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2769 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147589.pdf [firstpage_image] =>[orig_patent_app_number] => 10508554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6871781 [patent_doc_number] => 20030084471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Methods and compositions for RNA interference' [patent_app_type] => new [patent_app_number] => 10/055797 [patent_app_country] => US [patent_app_date] => 2002-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 24906 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20030084471.pdf [firstpage_image] =>[orig_patent_app_number] => 10055797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6646690 [patent_doc_number] => 20030104401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Gene silencing using sense DNA and antisense RNA hybrid constructs' [patent_app_type] => new [patent_app_number] => 10/052486 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12222 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104401.pdf [firstpage_image] =>[orig_patent_app_number] => 10052486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674340 [patent_doc_number] => 20030059943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Inhibition of expression of a target gene' [patent_app_type] => new [patent_app_number] => 09/994412 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4950 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059943.pdf [firstpage_image] =>[orig_patent_app_number] => 09994412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112629 [patent_doc_number] => 20020173478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Post-transcriptional gene silencing by RNAi in mammalian cells' [patent_app_type] => new [patent_app_number] => 09/993183 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173478.pdf [firstpage_image] =>[orig_patent_app_number] => 09993183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845302 [patent_doc_number] => 20020132787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Compositions and methods for nucleic acid delivery to the lung' [patent_app_type] => new [patent_app_number] => 09/978826 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7301 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132787.pdf [firstpage_image] =>[orig_patent_app_number] => 09978826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6784649 [patent_doc_number] => 20030066097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer\'s Disease' [patent_app_type] => new [patent_app_number] => 09/964678 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16480 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20030066097.pdf [firstpage_image] =>[orig_patent_app_number] => 09964678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7025367 [patent_doc_number] => 20050019761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Oligonucleotides, agents containing these oligonucleotides, and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/381869 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4046 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019761.pdf [firstpage_image] =>[orig_patent_app_number] => 10381869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7128063 [patent_doc_number] => 20050059807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Novel polypeptide-transcription factor xap-2-protein 49.72 and the polynucleotide encoding said polypeptide' [patent_app_type] => utility [patent_app_number] => 10/363870 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11506 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059807.pdf [firstpage_image] =>[orig_patent_app_number] => 10363870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 170784 [patent_doc_number] => 07662791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Gene silencing using mRNA-cDNA hybrids' [patent_app_type] => utility [patent_app_number] => 09/920342 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11969 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662791.pdf [firstpage_image] =>[orig_patent_app_number] => 09920342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683860 [patent_doc_number] => 20030119724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Ligands to enhance cellular uptake of biomolecules' [patent_app_type] => new [patent_app_number] => 09/888164 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24624 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119724.pdf [firstpage_image] =>[orig_patent_app_number] => 09888164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918721 [patent_doc_number] => 20050096282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases' [patent_app_type] => utility [patent_app_number] => 09/847601 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 32430 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096282.pdf [firstpage_image] =>[orig_patent_app_number] => 09847601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662120 [patent_doc_number] => 20060252716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Method for reversing the immunosuppressive effects of the melanoma inhibitory activity \"mia\"' [patent_app_type] => utility [patent_app_number] => 10/220265 [patent_app_country] => US [patent_app_date] => 2001-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 248 [patent_figures_cnt] => 248 [patent_no_of_words] => 3525 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252716.pdf [firstpage_image] =>[orig_patent_app_number] => 10220265 [rel_patent_id] =>[rel_patent_doc_number] =>)